Fig. 1
From: Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
Pathophysiology of Type 2 inflammation in severe asthma. IL-4 /IL-13 pathway. IL-5 pathway
Fig. 1 | Clinical and Molecular Allergy